XML 91 R78.htm IDEA: XBRL DOCUMENT v3.25.1
Stock-Based Compensation - Restriced Stock Activity (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Unrecognized stock-based compensation cost $ 8.9      
Unrecognized stock-based compensation cost, weighted-average period recognized 1 year 7 months 6 days      
Restricted stock        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Restricted stock award vesting period 3 years      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Unrecognized stock-based compensation cost $ 4.5      
Unrecognized stock-based compensation cost, weighted-average period recognized 1 year 3 months 18 days      
Shares outstanding (in shares) 5,218,626 3,974,419 2,784,610 2,144,804
Shares outstanding, Weighted Average Grant Date Fair Value (in dollars per share) $ 2.89 $ 3.54 $ 5.05 $ 6.60
Restricted stock 3,129,255 3,251,765 2,056,121  
Grant date fair value of restricted stock $ 2.66 $ 2.94 $ 4.07  
Vested (in shares) (1,576,652) (1,381,246) (1,114,513)  
Vested (in dollars per share) $ 4.11 $ 5.09 $ 6.08  
Canceled/Forfeited (in shares) (308,396) (680,710) (301,802)  
Canceled/Forfeited (in dollars per share) $ 2.82 $ 3.66 $ 5.74  
Performance shares        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Unrecognized stock-based compensation cost $ 4.4      
Unrecognized stock-based compensation cost, weighted-average period recognized 1 year 9 months 18 days      
Shares outstanding (in shares) 4,641,512 3,159,910 2,574,537 2,390,013
Shares outstanding, Weighted Average Grant Date Fair Value (in dollars per share) $ 3.24 $ 4.52 $ 5.26 $ 5.80
Restricted stock 2,076,818 1,816,429 1,325,418  
Grant date fair value of restricted stock $ 2.85 $ 3.16 $ 4.53  
Vested (in shares) (379,402) (566,891) (824,064)  
Vested (in dollars per share) $ 8.30 $ 4.00 $ 5.54  
Canceled/Forfeited (in shares) (215,814) (664,165) (316,830)  
Canceled/Forfeited (in dollars per share) $ 8.55 $ 4.32 $ 6.11  
Performance shares | 2019 Award        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Restricted stock     175,828  
Performance shares | 2020 Award        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Restricted stock   26,200    
Canceled/Forfeited (in shares)   (468,393)    
Performance shares | 2021 Award        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Restricted stock 22,351      
Canceled/Forfeited (in shares) (187,809)